China Pharma Hldgs Inc.
13F holders, Q4 2024 (December 31)5holders +1
2new positions
1sold out
$0.23avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding China Pharma Hldgs Inc. in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Two Sigma Securities, LLC ($16K), XTX Topco Ltd ($16K) and UBS Group AG ($7K).
- Company
- China Pharma Hldgs Inc.
- CUSIP
- 16941T302
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $9K |
| Exits | 1 | $3K |
All 13F filers, Q3 2024 → Q4 2024: 133,163 shares bought and 13,399 shares sold, net +119,764 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Two Sigma Securities, LLC | 0.00% | Add +266.6% | 69,832 | $16K |
| XTX Topco Ltd | 0.00% | Add +210.9% | 67,123 | $16K |
| UBS Group AG | 0.00% | New | 31,510 | $7K |
| Citigroup Inc. | 0.00% | New | 5,332 | $1K |
| First Community Trust NA | 0.00% | No change | 30 | $7 |
"% of holder's portfolio" is CHINA PHARMA HLDGS INC's weight in each manager's 13F, not the share of China Pharma Hldgs Inc. the manager owns.